- Supported exchanges /
- KQ /
- 142760.KQ
Bioleaders Corporation (142760 KQ) stock market data APIs
MOA Life Plus Co. Ltd. engages in the medicine and consumer business in South Korea. It offers P53, a target anti-cancer drug. The company's pipeline products include BLS-H01, which is in phase 3 clinical trial for the treatment of cervical cancer; BLC-H03, a vaccine adjuvant that is in preclinical stage; BLS-M07 that has completed phase 2b clinical trial for the treatment of cervical cancer; and BLS-M22 that has completed phase 1 clinical trial for the treatment of Duchenne muscular dystrophy. It also provides health functional food and raw materials, and cosmetics. The company was formerly known as Bioleaders Corporation and changed its name to MOA Life Plus Co. Ltd. in March 2024. MOA Life Plus Co. Ltd. was founded in 1999 and is headquartered in Yongin-Si, South Korea.
Bioleaders Corporation Financial Data Overview
| 1295 | |
| 1262 | |
| - | |
| 1305 | |
| 1250 | |
| 1221-4500 | |
| 47 772 M | |
| 37 735 K | |
| 18 436 M | |
| 0.721 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Bioleaders Corporation Fundamental Data is available in our Financial Data APIs
- Net Revenue 18 436 M
- EBITDA 147 M
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Bioleaders Corporation Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get Bioleaders Corporation End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
